Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
暂无分享,去创建一个
P. Merkel | J. Stone | C. Kallenberg | Hyon K. Choi | P. Monach | G. Hoffman | U. Specks | R. Spiera | S. Unizony | Z. Wallace | E. St.Clair | P. Brunetta | P. Seo | C. Langford | N. Lu | E. Miloslavsky | M. Cascino | P. Merkel | E. St.clair
[1] P. van Paassen,et al. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis. , 2015, Journal of the American Society of Nephrology : JASN.
[2] R. Zhong,et al. Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis , 2015, Arthritis Research & Therapy.
[3] A. Laviano,et al. Cachexia: clinical features when inflammation drives malnutrition , 2015, Proceedings of the Nutrition Society.
[4] A. Nakamura. Genotypes of the renin–angiotensin system and glucocorticoid complications , 2015, Pediatrics international : official journal of the Japan Pediatric Society.
[5] L. Alfredsson,et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis , 2014, Annals of the rheumatic diseases.
[6] P. Merkel,et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. , 2013, The New England journal of medicine.
[7] D. Gladman,et al. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis , 2013, Annals of the rheumatic diseases.
[8] J. Jacobs,et al. Increase of body mass index in a tight controlled methotrexate‐based strategy with prednisone in early rheumatoid arthritis: Side effect of the prednisone or better control of disease activity? , 2013, Arthritis care & research.
[9] P. Merkel,et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. , 2010, The New England journal of medicine.
[10] P. Merkel,et al. Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index , 2010, Annals of the rheumatic diseases.
[11] C. Ferro,et al. Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. , 2009, Arthritis and rheumatism.
[12] R. Collins,et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, Lancet.
[13] P. Merkel,et al. Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis. , 2008, Arthritis and rheumatism.
[14] Hyon K. Choi,et al. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. , 2007, Archives of internal medicine.
[15] Jeffrey R Curtis,et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. , 2006, Arthritis and rheumatism.
[16] M Cutolo,et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data , 2005, Annals of the rheumatic diseases.
[17] P. Merkel,et al. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). , 2005, Arthritis and rheumatism.
[18] T. MacDonald,et al. Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease , 2004, Annals of Internal Medicine.
[19] Ralph B D'Agostino,et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.
[20] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[21] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[22] B. Thiers. Obesity, Waist Circumference, Weight Change, and the Risk of Psoriasis in Women: Nurses' Health Study II , 2008 .
[23] Who Consultation on Obesity. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.